UI is developing an advanced holistic addiction treatment protocol, at its Kelburn Recovery Centre, that when combined with the planned ibogaine detox methodology is expected to transform the way we treat addiction and dramatically promote the welfare of families affected by addiction.
Excellence and IBO always go hand in hand when it comes to proving its potential in the market and leaving competitors way behind the bar. The shares are trading live at $0.05 with a significant spike
Universal Ibogaine Inc. is going to participate in the 2022 Virtual Growth Conference presented by Maxim Group LLC and hosted by M-Vest.
Universal Ibogaine Inc. a life science company listed on OTC with the ticker symbol $IBOGF has been seen with a higher day range difference. The day range is $0.0367-$0.0385.
$IBOGF has established a remarkable market cap as compared to its fellow penny stocks in the market, currently the market cap is valued at $9.07 Million which has increased twice within a week.
At the Kelburn Clinic, UI is developing a cutting-edge holistic addiction treatment protocol that, when combined with the anticipated ibogaine detox programme, will transform the way we treat addiction and dramatically enhance the lives of individuals and families plagued by addiction.
$IBOGF is trading swiftly in the market and observing a plenty of investor activities, the shares are trading live on OTC at $0.095 with an amazing 178% profit on value per share.
Dr. Sola, a co-founder of Universal Ibogaine and a member of its Board of Directors, has effectively administered over 3,700 ibogaine treatments, more than any other doctor in the world, at an independent clinic in Cancun, Mexico, where he is a partner.
$HEM is currently trading on the TSX-V effortlessly at $0.28 with no such loss percentage recorded yet and is expected to rise significantly in the upcoming week effectively.
$HEM have developed and established a firm market cap which has been on the rise steadily since the listing of the stock on TSX-V, currently the cap valuation is $19.773 Million.
Hemostemix Inc. announced that it will pay interest of $84,804.40 by issuing 446,339 Common Shares, using the March 2, 2022 closing price of $0.19 per share, to the convertible debenture holder in satisfaction of interest due on the outstanding principal amount of $2,500,000 for the period from inception, June 11, 2021, to December 31, 2021.
The stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.245 per unit
The stock today observed a brief rise in the value per share since its previous close, and the shares are actively being traded on TSX-V at $.24 per unit
Petroteq Energy Inc. is a fully integrated oil and Gas Company trading in TSX-V, Currently sits at $0.26 with market volume of 971.67K.
The market has begun with an excellent initial capital of $0.255 which later on took a move to $0.28 per share. Petroteq has acquired a volume of 2.05 million in the complete trading hour.
$PQE is currently well-positioned over the TSX-V with a remarkable performance of volume pick up, offering each share value of $0.255 today. While taking a brief analysis of straight 52 consecutive weeks is recorded as 0.41 the highest and 0.11 as the lowest offers as per the records.
NSE:BANKNIFTY Receiving lot of messages to share my views on Bank nifty and sharing with you all. #NSE:BANKNIFTY levels mentioned on chart, you can always ping me personally for your doubts. Happy LEarning !! #Banknifty #Herozero #myView
Petroteq holds a stable position over the TSX-V trading platform, currently running at $0.34 price per share, having an adequate volume of 179.01K with an overall market capitalization of 261.01 million+ traded on TSX-V.